Earth Science Tech, Inc. Reports Fiscal Year-End Results for March 31, 2025, with Revenue Exceeding $33.1 Million and Net Profit of $3.2 Million
For the fiscal year ended March 31, 2025, the Company reported the following results:
Cash: $1,473,228, compared to $697,721 as of March 31, 2024—an increase of $775,507, representing a 111.15% year-over-year improvement.
Total Assets: $7,066,721, compared to $3,881,336 as of March 31, 2024—an increase of $3,185,385, representing an 82.07% year-over-year improvement.
Revenue: $33,117,624, compared to $11,953,635 for the year ended March 31, 2024—an increase of $21,163,989, representing a 177.05% year-over-year improvement.
Gross Profit: $24,300,136, compared to $7,828,496 for the year ended March 31, 2024—an increase of $16,471,640, representing a 210.41% year-over-year improvement.
Net Profit: $3,253,635, compared to $812,139 for the year ended March 31, 2024—an increase of $2,441,496, representing a 300.63% year-over-year improvement.
Outstanding Shares: 295,347,903 shares of common stock issued and outstanding, compared to 309,981,819 shares as of March 31, 2024—a reduction of 14,633,916 shares, representing a 4.72% decrease in shares outstanding.
About Earth Science Tech, Inc.
Earth Science Tech, Inc. operates as a strategic holding company, focused on value creation through the acquisition, operational optimization, and management of its operating businesses. The Company's current operations include compounding pharmaceuticals, telemedicine and real estate development through its wholly owned subsidiaries: RxCompoundStore.com, LLC, Peaks Curative, LLC, Avenvi, LLC, Mister Meds, LLC ('Mister Meds'), and Earth Science Foundation, Inc., Las Villas Health Care, Inc., DOConsultations, LLC., and an 80% interest in MagneChef.
To learn more, please visit: www.EarthScienceTech.com
RxCompoundStore.com, LLC.
RxCompoundStore.Com, based in Miami, Florida, is a fully licensed compounding pharmacy authorized to fulfill prescriptions in the following states and territories: Arizona, Colorado, Delaware, Florida, Georgia, Illinois, Indiana, Iowa, Maine, Maryland, Minnesota, Missouri, Nevada, New Jersey, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, Rhode Island, Utah, Wisconsin and Puerto Rico. RxCompound is actively pursuing licensure in the remaining U.S. states.
To learn more please visit: www.RxCompoundStore.com
MisterMeds, LLC.
Mister Meds, acquired on October 1, 2024, is in Abilene, Texas. The pharmacy received full compounding licensure in March 2025. It operates out of a 5,000 sq. ft. facility owned by Avenvi and includes advanced sterile compounding capabilities with both positive and negative pressure environments, as well as hazardous drug handling. Mister Meds is currently applying for licensure in states not yet serviced by RxCompound.
To learn more please visit: www.mistermeds.com
Peaks Curative, LLC.
Peaks is a telemedicine referral platform offering asynchronous consultations for Peaks-branded compounded medications prepared at RxCompound and Mister Meds. The platform operates in states where either pharmacy is licensed. Through the development of its own healthcare provider network, MyOnlineConsultation.com, and ongoing licensure expansion for both pharmacies, Peaks aims to offer services nationwide. In addition, the company has recently expanded into the veterinary market through the acquisition of Zoolzy.com.
To learn more please visit: www.PeaksCurative.com
Las Villas Health Care, Inc.
Las Villas is a brick-and-mortar healthcare facility dedicated to the Spanish speaking community. Our expert-led services include advanced sexual health treatments, and customized solutions to enhance physical performance. We combine compassionate, personalized care with clear, trustworthy education—empowering you to take control of your health with confidence.
To learn more please visit: https://villashealth.com
Doconsultation.com, LLC.
Doconsultation was born with a passion to modernize the availability and delivery of home therapies. DOConsultations providers tailor a medication plan around your health and wellness goals and follow up with our patients to ensure results, while our partner pharmacies conveniently ship directly to your door.
To learn more please visit: https://doconsultations.com/
Avenvi, LLC.
Avenvi is a diversified real estate company engaged in development, asset management, and financing. With a growing portfolio of real estate holdings, Avenvi provides turnkey solutions from development to end-user financing. It also manages investment activities for ETST and oversees the Company's ongoing $5 million share repurchase program.
To learn more please visit: www.avenvi.com
MagneChef
MagneChef is a direct-to-consumer retail brand. Utilizing its patents and intellectual properties, the company aims to develop new products that can be marketed and sold online. Currently, the company has developed products for cooking. MagneChef is in the process of expanding its product line for new offerings that incorporate its intellectual property.
To learn more please visit: https://magnechef.com/
About Earth Science Foundation, Inc.
Earth Science Foundation Inc. a 501(c)(3) nonprofit organization incorporated on February 11, 2019, is the charitable arm of ETST. ESF accepts grants and donations to assist individuals who need financial support for prescription costs at both RxCompound and Mister Meds.
SAFE HARBOR ACT: Forward-Looking Statements. Except for historical information, the matters discussed herein may be considered 'forward-looking' statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended.
Such statements include declarations regarding the intent, belief or current expectations of the Company and its management, including, without limitation, future-oriented statements related to cash flow, gross margins, revenues, and expenses. These statements are based on and reflect our current expectations, estimates, assumptions and/or projections, our perception of historical trends and current conditions, as well as other factors that we believe are appropriate and reasonable under the circumstances. Forward-looking statements generally can be identified by the fact that they do not relate strictly to historical or current facts. They may include forward-looking words such as 'expect,' 'expectation,' 'believe,' 'anticipate,' 'may,' 'could,' 'intend,' 'belief,' 'plan,' 'estimate,' 'target,' 'predict,' 'likely,' 'seek,' 'project,' 'model,' 'ongoing,' 'will,' 'should,' 'forecast,' 'outlook' or similar terminology. Forward-looking statements are subject to a number of risks and uncertainties that may cause the Company's actual results to differ materially from our intent, belief or current expectations, including, inter alia, the markets for the Company's products and services, costs of goods and services, other expenses, government regulations, litigations, and general business conditions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, estimated or projected. The Company assumes no obligation to revise or update any forward-looking statements for any reason, except as required by law.
Company Contact:Giorgio R. SaumatCEO and Chairman of the Board(305) 724-5684IR@earthsciencetech.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
25 minutes ago
- Yahoo
Why famed short-seller Andrew Left says he's betting against Palantir: 'It's become so absurd'
Short-seller Andrew Left says he's betting against Palantir. The AI-powered data company has seen its stock soar this year. Left says he likes the company, but its stock valuation is unjustifiable. Palantir stock seems unstoppable this year, but its astronomical rally has drawn the eye of at least one renowned short-seller. Andrew Left, founder of Citron Research, told Fox Business this week that he's betting against the AI-powered data software company amid its colossal 144% stock surge in 2025. The stock has rallied most recently after reporting strong second-quarter earnings on August 4. Left made it clear that despite Palantir's status as an AI and retail darling, he sees its valuation as extreme. "If this was the greatest company that was ever created and we gave it the same multiples as, let's say Nvidia in 2023, the stock still can get cut by two thirds. And that would be like 35 times sales." Palantir's price-to-sales ratio this month is hovering around 80x, while its forward price-to-earnings ratio was 290x on Thursday. "I've stopped even looking at the ratio because it's become so absurd," Left said. "There's never been a company that has that type of multiple or that type of PE that's not corrected 50%." The short-seller highlighted Palantir's significant following among retail traders, which he suggested is a negative for the stock. Left drew the ire of retail investors when his firm bet against the original meme stock, Gamestop. His other high-profile short bets include Hertz, EV startup Nikola, and Valeant. Once known for his high short-selling activity and social media presence, Left has toned it down recently. In July 2024, the US Securities and Exchange Commission charged him with market manipulation and securities fraud. In May, a federal judge rejected Left's bid to dismiss the case. Left's firm continues to share its reports and perspectives on X. On August 13, it called out an X post by CNBC commentator Jim Cramer when he issued a bullish take on Palantir stock. "Palantir at these levels isn't an "easy money" story; it's a high-multiple, hype-driven narrative," Citron wrote. Read the original article on Business Insider Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
25 minutes ago
- Yahoo
Malibu Boats, Inc. Announces Earnings Release Date and Conference Call Information for Fourth Quarter and Full-Year Fiscal 2025 Financial Results
LOUDON, Tenn., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Malibu Boats, Inc. (Nasdaq: MBUU) announced today that it will release its fourth quarter and full-year fiscal 2025 financial results on Thursday, August 28, 2025, before the market opens. Following the release, the company's management will host a conference call to discuss the results at 8:30 a.m. Eastern Time on the same day. The call will be hosted by Malibu's Chief Executive Officer, Steve Menneto, and Chief Financial Officer, Bruce Beckman. Investors and analysts are invited to listen to the conference call by dialing (844) 695-5523 or (412) 317-0699. Alternatively, interested parties can listen to a live webcast of the conference call by logging on to the Investor Relations section on the Company's website at A replay of the webcast will also be archived on the Company's website for twelve months. About Malibu Boats, Inc. Based in Loudon, Tennessee, Malibu Boats, Inc. (MBUU) is a leading designer, manufacturer and marketer of a diverse range of recreational powerboats, including performance sport, sterndrive and outboard boats. Malibu Boats, Inc. is the market leader in the performance sport boat category through its Malibu and Axis boat brands, the leader in the 20' - 40' segment of the sterndrive boat category through its Cobalt brand, and in a leading position in the saltwater fishing boat market with its Pursuit and Cobia offshore boats and Pathfinder, Maverick, and Hewes flats and bay boat brands. A pre-eminent innovator in the powerboat industry, Malibu Boats, Inc. designs products that appeal to an expanding range of recreational boaters, fisherman and water sports enthusiasts whose passion for boating is a key component of their active lifestyles. For more information, visit or Contacts Malibu Boats,
Yahoo
25 minutes ago
- Yahoo
Activist Starboard buys more Salesforce stock after first demanding change in 2022
By Svea Herbst-Bayliss NEW YORK (Reuters) -Activist Starboard Value, one of the first investors to publicly push Salesforce to make changes three years ago, increased its stake in the U.S. software company by almost 50% in the second quarter, according to a regulatory filing on Thursday. The hedge fund reported owning 1.3 million shares in Salesforce on June 30, compared with 849,679 shares at the end of the first quarter when it boosted its stake by almost 52%. The move comes as the company's stock price has lost nearly 30% since January and is off nearly 9% over the last 12 months. Salesforce, which has a market value of $223 billion, came under intense pressure from a handful of activist investors in late 2022 and early 2023. But many who publicly pushed for changes cut their stakes or exited completely by the middle of 2023 after the company reported better results, added a new director to the board and made other changes. Now the pressure may be increasing again with Starboard, which is known to revisit earlier investments if the company is seen as backsliding on promises, loading up on the stock. While Salesforce's stock price gained nearly 100% in 2023, Starboard's chief executive, Jeffrey Smith, said late last year that the company still had room to become more efficient and profitable. A Starboard spokesperson could not be reached for comment on Thursday. The firm also increased its holding in drugmaker Pfizer by 10.5% to 8.5 million shares, less than a year after unveiling a $1 billion stake in the company and pushing it to improve performance. At Autodesk, where the hedge fund settled its fight with the software design company in April, Starboard cut its stake by nearly 27%, the filing shows. While Thursday's filing is backward-looking, the so-called 13F filings, which detail what U.S. stocks a fund manager owned at the end of the previous quarter, are closely watched for possible investment trends.
